7169-08-6

Upstream product

• 118-41-2 Eudesmic acid 
• 92157-76-1 methyl 2,3,4,5,6-pentamethoxybenzoate 
• 6307-91-1 2,6-dibromo-3,4,5-trimethoxy-benzoic acid 
• 91556-09-1 2,3,4,5,6-pentamethoxybenzoic acid 

Downstream Products

• 1322640-35-6 C₂₇H₂₈O₉ 
• 1322640-36-7 C₂₇H₂₈O₉ 
• 29201-96-5 C₂₇H₂₈O₉ 
• 34810-62-3 3′-methoxy-4′-hydroxy-5,6,7,8-tetramethoxyflavone 
• 29201-97-6 4'-benzyloxy-3',5,6,7,8-pentamethoxyflavone 
• 29201-99-8 3'-benzyloxy-4',5,6,7,8-pentamethoxyflavone 
• 3162-28-5 2-hydroxy-3,4,5,6-tetramethoxyacetophenone 
• 34810-60-1 2-(3-Methoxy-4-benzyloxy-benzoyloxy)-3,4,5,6-tetramethoxyacetophenon 
• 80140-31-4 3',4'-dihydroxy-5,6,7,8,-tetramethoxyflavone 
• 80140-30-3 3',4'-Dibenzyloxy-5,6,7,8-tetramethoxyflavone 
• 80140-29-0 2-Hydroxy-3',4'-dibenzyloxy-3,4,5,6-tetramethoxydibenzoylmethane 
• 80140-28-9 2-(3',4'-Dibenzyloxy)benzoyloxy-3,4,5,6-tetramethoxyacetophenone 
• 112448-39-2 2-(3-hydroxy-4-methoxyphenyl)-5,6,7,8-tetramethoxy-4H-1-benzopyran-4-one 

Relevant academic research and scientific papers

Nobiletin metabolites: Synthesis and inhibitory activity against matrix metalloproteinase-9 production

A divergent synthesis of nobiletin metabolites was developed through highly oxygenated acetophenone derivative. We used commercially available methyl 3,4,5-trimethoxybenzoate as a starting material for concise preparation of the key intermediate, 2′-hydro